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Although SPE-39 is a binding protein to Vps33B that is one of the subunit in the mammalian HOPS
complex, the elements of SPE-39 function remain unknown. Here, we show that tyrosine phosphor-
ylation of SPE-39 following EGF stimulation plays a role in the stability of SPE-39 itself. Ubiquitina-
tion of the C-terminal region of SPE-39 was also elevated in response to EGF stimulation, and this
process was regulated by the phosphorylation of Tyr-11 in SPE-39. However, association of Vps33B
with SPE-39 inhibited the elevation of ubiquitination of SPE-39 following EGF stimulation, which
might be responsible for the stabilization of SPE-39. Furthermore, an opposing functional relation-
ship between SPE-39 and Vps33B on the downregulation of the EGF receptor was observed in EGF-
stimulated COS-7 cells.
Structured summary of protein interactions:
Vps33B and EGFR colocalize by ﬂuorescence microscopy (View interaction)
Vps33B and SPE-39 physically interact by anti bait coimmunoprecipitation (View interaction)
Vps33B and SPE-39 physically interact by anti tag coimmunoprecipitation (View interaction)
Vps33B and SPE-39 colocalize by ﬂuorescence microscopy (View interaction)
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The homotypic fusion and vacuole protein sorting (HOPS) com-
plex originally discovered in yeast, has essential roles in fusion of
membranes with lysosomes or lysosome-related organelles in met-
azoans [1,3]. The HOPS complex comprises with four subunits of
class C vacuolar protein sorting (Vps) proteins (Vps11, Vps16,
Vps18 and Vps33) and two class B Vps proteins (Vps39 and
Vps41) [2–4].
Recently, mutations in the gene encoding human Vps33B were
reported to arthrogryposis-renal dysfunction-cholestasis syndrome
(ARC), which is associated with platelet dysfunction and abnormal-
ities in polarized liver and kidney cells [5].
SPE-39 has been identiﬁed as a protein that binds to Vps33 in
Caenorhabditis elegans; this interaction is essential for vesicular
trafﬁcking during spermatogenesis [6]. The human ortholog ofchemical Societies. Published by E
and Environmental Sciences,
hobara 727-0023, Japan. Fax:
onishi).SPE-39 (hSPE-39) is also known to associate with both subtypes
of Vps33A and Vps33B in mammalian cells [4,7]. Furthermore,
other research groups found hSPE-39 mutations, but not Vps33B
mutations in individuals with ARC. The complex formed between
hSPE-39, which is also named VIPAR (Vps33B-interacting protein
involved in polarity and apical protein restriction), and Vps33B
might be involved in the stabilization of the apical membrane pro-
teins [8]. However, the precise mechanisms by which this occurs
remain obscured.
SPE-39 (also known as FLJ12707 or C14ORF133) was originally
identiﬁed through tyrosine phosphoproteomics, and it has been re-
ported that Tyr-11 is phosphorylated following certain stimuli in
cultured cells [9–11]. However, further characteristics of its tyro-
sine phosphorylation have yet to be conducted.
In this study, we conﬁrmed the phosphorylation of Tyr-11 in
SPE-39 upon EGF stimulation. SPE-39 is an ubiquitinated protein,
and the level of its ubiquitination is elevated in EGF-stimulated
cells. We focused on the stability and function of SPE-39 in re-
sponse to EGF stimulation, and the relationship between SPE-39
tyrosine phosphorylation and ubiquitination and the SPE-39/
Vps33B complex.lsevier B.V. All rights reserved.
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2.1. Cell culture, transfection, and reagents
COS-7 cells were maintained in Dulbecco’s modiﬁed Eagle’s
medium supplemented with 10% fetal bovine serum (FBS),
100 lg/ml of streptomycin, and 100 units/ml of penicillin. Trans-
fection was carried out by electroporation using the Gene-Pulser
system (Bio-Rad). EGF (100 ng/ml, Sigma) dissolved in serum-free
medium was added.
2.2. cDNA cloning and vector constructions
SPE-39 (FLJ12707) cDNA, provided by the National Institute of
Technology and Evaluation, Japan, was subcloned into pFLAG-
CMV6a (Sigma) to be expressed as an N-terminal FLAG-tagged.
Vps33B cDNAswere purchased fromOpenBiosystems, inserted into
a pEGFP-C vector, and expressed as GFP-fused proteins at the N-ter-
minus. Point mutations were introduced using the QuikChange Kit
(Stratagene), and mutations were veriﬁed by DNA sequencing.
2.3. Antibodies
An anti-SPE-39 rabbit polyclonal antibody was raised against
peptides having an additional cysteine residue at the N-terminal
end of the SPE-39 amino acid sequence, KGDEEEYWNSSKF (amino
acids 5–17). The peptides were coupled to keyhole limpet hemocy-
anin and used to immunize rabbits. The antibody was puriﬁed
using HiTrap N-hydroxysuccinimide-activated Sepharose columns
(GE Healthcare) coupled with an immunizing antigen. An anti-
EGF receptor rabbit polyclonal antibody was raised against a 15-
amino acid peptide corresponding to the C terminus of the protein
[12]. Other antibodies were obtained commercially from various
companies: anti-FLAG M2 (Sigma), anti-phosphotyrosine (4G10;
Upstate Biotech Inc.), anti-Vps33B (Abcam), and anti-HA antibody
(12CA5; Roche).
2.4. Immunoprecipitation and immunoblot analysis
The following procedureswere carried out at temperatures rang-
ing from 0 to 4 C. The transfected cells were lysed in a lysis buffer
containing 20 mM Tris–HCl (pH 7.5), 1 mM EDTA, 10 mM dithio-
threitol, 1% Triton X-100, 150 mMNaCl, 10 mMNaF, 1 mMNa3VO4,
and a complete protease inhibitor mixture (Roche Applied Science)
to produce a total cell lysate (TCL). For the immunoprecipitation
experiments, the total cell lysate was centrifuged, and the superna-
tant was incubated for 2 h with either the primary antibody or an
anti-FLAG afﬁnity gel (Sigma). Protein G-Sepharose (GE Healthcare)
was added, and the resultingmixturewas rotated at 4 C for 1 h. The
beads were subsequently washed 3 times with the lysis buffer. The
processed samples were treated as described previously.
2.5. Fluorescence microscopy analysis
Transfected cells were ﬁxed and observed as described previ-
ously [13].
3. Results
3.1. Identiﬁcation of the tyrosine phosphorylation site in SPE-39 upon
EGF stimulation
Although SPE-39 protein functions as a Vps33B-interacting
protein involved in polarity and apical protein restriction, it was
originally identiﬁed as a tyrosine-phosphorylated protein in phos-
phoproteomic studies. Tyr-11 was identiﬁed as the site of phos-phorylation in ﬁbroblast growth factor-3 (FGF3)-stimulated cells,
as well as in pervanadate- and calyculin-treated T-cell leukemia
cells [9–11].
We determined that SPE-39 is also phosphorylated upon EGF
stimulation of COS-7 cells, and Tyr-11 was observed to be a major
site of phosphorylation (Fig. 1B, C). The surrounding amino acid
sequence of Tyr-427 is also a consensus motif for phosphorylation
by the EGF receptor (Fig. 1A). However, immunoprecipitation stud-
ies using deletion mutants revealed that EGF treatment did not
result in Tyr-427 phosphorylation (Fig. 1B).
We also determined the effect of EGF stimulation on the interac-
tions between endogenous SPE-39 and Vps33B in HeLa cells. Com-
pared to non-stimulated cells, the amount of Vps33B bound to
SPE-39 was slightly reduced in EGF-stimulated cells (Fig. 1D). Next,
COS-7 cells expressing FLAG–SPE-39 and GFP–Vps33B were lysed,
and the FLAG–SPE-39 protein was immunoprecipitated with the
anti-FLAG antibody. Again, the amount of GFP–Vps33B bound to
the immunoprecipitated FLAG–SPE-39 was slightly decreased in
EGF-stimulated cells compared to non-stimulated cells. This
decrease was not observed with the Y11F mutant of SPE-39
(Fig. 1E). Thus, tyrosine phosphorylation of SPE-39 upon EGF stimu-
lation has an inhibitory effect on the binding of SPE-39 and Vps33B.
3.2. Effect of SPE-39 tyrosine phosphorylation and ubiquitination on
the interaction between SPE-39 and Vps33B
SPE-39 has been identiﬁed as a protein that interacts with
Vps33, the latter being a component of the HOPS complex. This
complex has important roles for distribution of ubiquitinated cargo
protein from the plasma membrane to lysosomes. Therefore, we
speculated that this protein complex plays some roles in the ubiq-
uitin–proteasome pathway.
Anti-FLAG immunoprecipitation experiment was performed
with lysate from cells the co-expressing FLAG-tagged SPE-39 and
HA-tagged ubiquitin. In COS-7 cells, several bands conjugated with
HA-tagged ubiquitin might represent polyubiquitinated SPE-39
(Fig. 2B, lane 2). Interestingly, the level of ubiquitination of a
C-terminal truncated mutant of SPE-39 (1–400) was decreased
compared with the wild type or the mutant of SPE39 (1–420)
(Fig. 2B, lane 4 and 6). Therefore, the ubiquitination site in SPE-
39 might be located in its C-terminal region.
Ubiquitination of some proteins is upregulated in cells with
growth factors stimulation [14,15]. The ubiquitionation of SPE-39
was upregulated by EGF-stimulation (Fig. 2C, lane 3). However, this
elevation did not occur in cells overexpressing GFP–Vps33B
(Fig. 2C, lanes 4 and 5). We also found that the level of poly-ubiq-
uitination of SPE-39, but not of the SPE-39(Y11F) tyrosine phos-
phorylation mutant, increased with EGF stimulation (Fig. 2C,
lanes 6 and 7). Therefore, tyrosine phosphorylation of SPE-39
may regulate its EGF-mediated ubiquitination.
3.3. Effect of SPE-39 tyrosine phosphorylation and interaction with
Vps33B on the stabilization of SPE-39, and opposing functional
relationship between SPE-39 and Vps33B
Multiple-posttranslational modiﬁcations occur in SPE-39 in an
EGF-dependent manner, and we found that exogenously expressed
FLAG–SPE-39 was degradated in cells that had been treated with
EGF for several hours (Fig. 3A, set of left 3 lanes). However, this
instability of SPE-39 was limited by the overexpression of GFP–
Vps33B (Fig. 3A, set of middle 3 lanes). Furthermore, upon EGF
treatment, the degradation of the SPE-39(Y11F) phosphorylation
mutant in the absence of GFP–Vps33B was attenuated compared
with that of the wild-type protein. (Fig. 3A, set of right 3 lanes).
Therefore, the instability of SPE-39 was suppressed in the absence
of its phosphorylation.
Fig. 1. Effect of tyrosine phosphorylation of SPE-39 on the binding of SPE-39 to Vps33B. (A) Schematic representation of SPE-39. The positions of the representative tyrosine
residues in SPE-39 are indicated. The numbers indicate amino acid residues. (B, C) Tyrosine phosphorylation and identiﬁcation of the site of tyrosine phosphorylation in SPE-
39 upon EGF stimulation. COS-7 cells were transfected with each indicated plasmid encoding the FLAG-tagged SPE-39 derivatives in which tyrosine residues {Y} had been
substituted with phenylalanine residues {F}. Cells were treated with (+) or without () EGF stimulation for 10 min, and each FLAG-tagged variant was immunoprecipitated
with the respective anti-FLAG antibody. Immunoblot analysis was performed using anti-phosphotyrosine (upper panel) and anti-FLAG antibodies (lower panel). (D, E) The
effects of tyrosine phosphorylation of SPE-39 on its binding to Vps33B. Co-immunoprecipitation studies were carried out using cell lysates from HeLa cells (D) or the COS-7
cells overexpressing FLAG–SPE-39 (E). Endogenous SPE39 and each FLAG-tagged variant were immunoprecipitated with an anti-SPE39 and an anti-FLAG antibody,
respectively. Immunoblot analysis was carried out using indicated antibodies. Bands were quantitated using reverse image scanning densitometry by normalizing the band
intensity of the co-immunoprecipitated Vps33B to the band intensity of the immunoprecipitated endogenous SPE-39 (D) or FLAG–SPE-39 (E). The representative results from
three independent experiments are indicated below each panel. The amounts of co-immunoprecipitated Vps33B from non-stimulated cells are normalized to the control.
FL: FLAG-tagged, Y11F: SPE-39 mutant with Tyr-11 replaced by Phe.
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and the EGF receptor. GFP–Vps33B was mainly co-localized with
the EGF receptor in the COS-7 cells stimulated with EGF for
30 min (Fig. 3C, d–f). In addition, expression of GFP–Vps33B accel-
erated the downregulation of the EGF receptor in the EGF-stimu-
lated COS-7 cells (Fig. 3B, middle panel). In contrast, exogenous
expression of SPE-39 inhibited the co-localization of endogenous
EGF receptor and GFP–Vps33B. FLAG–SPE-39 was not co-localized
with the EGF receptor (Fig. 3C, a–c), but GFP–Vps33B was involved
into the SPE-39 positive-vesicules (Fig. 3C, g–j). Concurrent with
the abnormal dissociation of Vps33B from EGF receptor-positive
vesicles in cells expressing with the FLAG–SPE-39, the effect of
Vps33B on the downregulation of the EGF receptor was diminished
(Fig. 3B, lower panel).
4. Discussion
Each mutation of SPE-39 or Vps33 is linked to disordered apical
protein restriction in the liver and kidney in ARC [5,7]. This is in
part because the levels of E-cadherin at the adherens junctionsand the level of CEACAM5 at the apical membrane protein are reg-
ulated by Vps33B and SPE-39. Reducing the expression of each pro-
tein by knockdown or knockout induced degradation of the apical
membrane protein, because of its mis-sorting to basolateral mem-
branes and into the late endosomes and lysosomes [7]. For proper
maintenance of this pathway, the expression levels of each protein
must be correctly regulated. However, the precise mechanisms by
which these proteins regulated are unknown. In this study, we pro-
vide experimental evidence that post-translational modiﬁcation of
SPE-39 has a signiﬁcant role in its stability. Speciﬁcally, the phos-
phorylation of Tyr-11 and ubiquitination near the C-terminus of
SPE-39 might be closely linked in EGF-stimulated cells. We showed
that SPE-39 was protected against proteolytic degradation by asso-
ciation with Vps33B (Fig. 3A), and that the interaction between
SPE-39 and Vps33B was weakly inhibited by EGF stimulation
(Fig. 1D, E). Therefore, each modiﬁcation of SPE-39—its association
with Vps33B and phosphorylation of its Tyr-11 residue—might
have opposing effects on its stabilization in the EGF-stimulated
cells. Furthermore, Tyr-11 phosphorylation of SPE-39 might regu-
late ubiquitination of SPE-39 in response to EGF stimulation
Fig. 2. SPE-39 is an ubiquitinated protein. (A) Schematic representation of SPE-39. (B) The numbers indicate amino acid residues. COS-7 cells were transfected with the
indicated plasmids, and immunoprecipitation of the expressed proteins from the cell lysates was performed. Immunoblot analysis was carried out using anti-FLAG (left panel)
and anti-HA (right panel) antibodies. Ubiquitinated SPE-39 is indicated by an arrow. HA-Ub: HA-tagged ubiquitin, pUb: poly-ubiquitinated. (C) Effect of Vps33B on the
ubiquitination of SPE-39. COS-7 cells were transfected with the indicated plasmids, and expressed proteins were immunoprecipitated from lysates from cells treated with (+)
or without () EGF for 30 min. Immunoprecipitation and immunoblotting were performed as described in Fig. 2. Bands were quantitated using reverse image scanning
densitometry by normalizing the band intensity of the poly-ubiquitinated SPE-39 to the band intensity of the immunoprecipitated FLAG-tagged proteins. The representative
results from three independent experiments are indicated below each panel. The amounts of poly-ubiquitinated SPE-39 from non-stimulated cells are normalized to the
control (lane 2).
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is to ensure that the normal structure of the liver and kidney cells,
with apical basolateral polarity, is maintained by regulating theexpression of adherent proteins such as E-cadherin. EGF and HGF
are important factors regulating the formation of a liver progenitor
cell line [16]. Cell motility is upregulated in cells with growth
Fig. 3. (A) Effect of Vps33B expression on the protein stability of SPE-39 in response to EGF stimulation. The amount of each protein was monitored by immunoblotting with
speciﬁc antibodies. Proteins (20 lg) were applied from each total cell lysate prepared from COS-7 cells expressing each protein stimulated with EGF for the indicated times.
The levels of the FLAG–SPE-39 expression were quantiﬁed by densitometry. The representative results from three independent experiments are indicated below each panel.
The amounts of FLAG-protein at each time point are normalized to the control (lane of each 0 time). (B) Vps33B accelerated the downregulation of the EGF receptor, which
was suppressed by co-expression of SPE-39. Effects of GFP–Vps33B and FLAG–SPE-39 expression on the downregulation of the EGF receptor. The amount of each protein was
monitored by immunoblotting with anti-EGF receptor antibody. Twenty micrograms of protein of each whole cell lysate prepared from COS-7 cells transfected with the mock
vector (upper panel), GFP–Vps33B (middle panel), or both GFP–Vps33B and SPE-39 stimulated with EGF for the indicated times was applied. The levels of the EGF receptor
expression were quantiﬁed by densitometry. The representative results from three independent experiments are indicated below each panel. The amounts of EGF receptor at
each time point are normalized to the control (lane of each 30 min). (C) Subcellular localization of FLAG–SPE-39, EGF receptor and GFP–Vps33B with EGF treatment. COS-7
cells expressing FLAG–SPE-39 (a–c), GFP–Vps33B (d–f) or both proteins (g–j) with EGF treatment for 30 min were processed for immunoﬂuorescence staining using anti-FLAG
(a and h) and anti-EGF receptor (b, e and i), respectively. The scale bars represent 10 lm.
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contact during cell growth or differentiation. It is possible that
the degradation of SPE-39 induced by its secondary modiﬁcations
is involved in controlling the strength of cell–cell contacts due to
reduced expression of adherent proteins.
The EGF receptor is internalized from the plasma membrane
into the lysosomes upon ligand stimulation [17,18], and several
HOPS-related proteins can affect the distribution and degradation
of the EGF receptor. For example, degradation of the EGF receptor
is dramatically reduced by depletion of Vps11 [19]. Depletion of
SPE-39 induced a delay in the downregulation of the EGF receptor30 min after the addition of EGF. However, after several hours of
EGF treatment, the amount of the EGF receptor was almost identi-
cal in cells with or without depletion of SPE-39 [4].
In this study, we conﬁrmed the enhancement of the EGF recep-
tor degradation by overexpression of Vps33B (Fig. 3B). In cells with
low-level expression of SPE-39, the HOPS complex including GFP–
Vps33B might be involved in the EGF-positive vesicles, which
accelerates the deliver of the EGF receptor to the lysosomes. How-
ever, response to EGF stimulation and subcellular localization of
the HOPS complex may change or be disturbed by the high-afﬁnity
interaction of Vps33B and SPE-39 in cells overexpressing
2250 A. Ishii et al. / FEBS Letters 586 (2012) 2245–2250FLAG–SPE-39 (Fig. 3C). Because the stability and the quantity of
SPE-39 in cells were altered with its phosphorylation and ubiquiti-
nation, these modiﬁcations may affect the function of the HOPS
complex.
The mechanism of endocytic trafﬁcking is conserved from yeast
to humans, and the factors in each species that participate in these
events are also highly conserved [1,2]. However, several subtypes of
the ESCRT and HOPS complexes have been identiﬁed in humans but
not in yeasts [2,20]. Furthermore, posttranslational modiﬁcations
are diverse among each subtype [21]. Thus, further studies to char-
acterize the relationship between the tyrosine phosphorylation of
SPE-39 and its stability in EGF-stimulated cells are warranted.
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